In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. 2009

Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
Molecular Immunology Unit, Hospital Universitario Puerta de Hierro, Madrid, Spain.

There is an urgent need to develop new and effective agents for cancer targeting. In this work, a multivalent antibody is characterized in vivo in living animals. The antibody, termed "trimerbody", comprises a single-chain antibody (scFv) fragment connected to the N-terminal trimerization subdomain of collagen XVIII NC1 by a flexible linker. As indicated by computer graphic modeling, the trimerbody has a tripod-shaped structure with three highly flexible scFv heads radially outward oriented. Trimerbodies are trimeric in solution and exhibited multivalent binding, which provides them with at least a 100-fold increase in functional affinity than the monovalent scFv. Our results also demonstrate the feasibility of producing functional bispecific trimerbodies, which concurrently bind two different ligands. A trimerbody specific for the carcinoembryonic antigen (CEA), a classic tumor-associated antigen, showed efficient tumor targeting after systemic administration in mice bearing CEA-positive tumors. Importantly, a trimerbody that recognizes an angiogenesis-associated laminin epitope, showed excellent tumor localization in several cancer types, including fibrosarcomas and carcinomas. These results illustrate the potential of this new antibody format for imaging and therapeutic applications, and suggest that some laminin epitopes might be universal targets for cancer targeting.

UI MeSH Term Description Entries
D007128 Immunoglobulin Fragments Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques. Antibody Fragment,Antibody Fragments,Ig Fragment,Ig Fragments,Immunoglobulin Fragment,Fragment, Antibody,Fragment, Ig,Fragment, Immunoglobulin,Fragments, Antibody,Fragments, Ig,Fragments, Immunoglobulin
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer

Related Publications

Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
October 2015, Molecular immunology,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
July 2005, Cancer research,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
April 1984, Radioisotopes,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
January 2014, Proceedings of the National Academy of Sciences of the United States of America,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
October 1981, The Journal of clinical investigation,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
March 2012, ACS nano,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
March 2009, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
January 2004, Methods in molecular biology (Clifton, N.J.),
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
April 2004, Protein engineering, design & selection : PEDS,
Angel M Cuesta, and David Sánchez-Martín, and Laura Sanz, and Jaume Bonet, and Marta Compte, and Leonor Kremer, and Francisco J Blanco, and Baldomero Oliva, and Luis Alvarez-Vallina
November 2014, Biomaterials,
Copied contents to your clipboard!